Juno Therapeutics Inc has acquired Stage Cell Therapeutics GmbH, a privately-owned biotechnology company in Germany, in order gain access to research and manufacturing technologies and to a pipeline of clinical and preclinical assets. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
